triazoles has been researched along with 3-fluoro-2-(4-((2-nitro-1h-imidazol-1-yl)methyl)-1h-1,2,3-triazol-1-yl)propan-1-ol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, HJ; Brans, B; De Ruysscher, D; Dingemans, AM; Dubois, L; Hochstenbag, M; Janssen, MH; Kolb, H; Lalisang, R; Lambin, P; Ollers, M; van Dongen, GA; van Loon, J; Windhorst, B; Zhang, J | 1 |
| Alpaugh, K; Bélanger, MJ; Doss, M; Hostetler, ED; Kolb, HC; Stubbs, JB; Yu, JQ; Zhang, JJ | 1 |
| Carlin, S; Humm, JL | 1 |
| Chen, L; Guan, Y; Kolb, HC; Walsh, JC; Zhang, J; Zhang, Z | 1 |
| Betts, HM; Dutton, D; Perkins, AC; Turton, DR | 1 |
| Brunetti, JC; Chien, D; Kolb, H; Lambin, P; Moon, DH; Srinivas, SM; Subramaniam, RM; Szardenings, K; van Elmpt, W; Waxman, A; Zegers, CM | 1 |
| Das, M; Dingemans, AC; Even, AJG; Lambin, P; Mottaghy, FM; Oellers, M; Reymen, B; Troost, EGC; van Elmpt, W; Wildberger, JE; Zegers, CML | 1 |
| Betts, HM; Christian, JA; Foweraker, K; O'Connor, RA; Pascoe, AC; Perkins, AC; Vinayakamoorthy, V | 1 |
1 review(s) available for triazoles and 3-fluoro-2-(4-((2-nitro-1h-imidazol-1-yl)methyl)-1h-1,2,3-triazol-1-yl)propan-1-ol
| Article | Year |
|---|---|
PET of hypoxia: current and future perspectives.
Topics: Etanidazole; Humans; Hydrocarbons, Fluorinated; Hypoxia; Nitroimidazoles; Positron-Emission Tomography; Radioactive Tracers; Triazoles | 2012 |
4 trial(s) available for triazoles and 3-fluoro-2-(4-((2-nitro-1h-imidazol-1-yl)methyl)-1h-1,2,3-triazol-1-yl)propan-1-ol
| Article | Year |
|---|---|
PET imaging of hypoxia using [18F]HX4: a phase I trial.
Topics: Aged; Cell Hypoxia; Dose-Response Relationship, Drug; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Time Factors; Triazoles | 2010 |
Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.
Topics: Animals; Biomarkers; Female; Haplorhini; Humans; Hypoxia; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Species Specificity; Tomography, X-Ray Computed; Triazoles; Whole Body Imaging | 2010 |
Repeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial.
Topics: Aged; Biological Transport; Cell Hypoxia; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Triazoles | 2015 |
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nitroimidazoles; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2016 |
3 other study(ies) available for triazoles and 3-fluoro-2-(4-((2-nitro-1h-imidazol-1-yl)methyl)-1h-1,2,3-triazol-1-yl)propan-1-ol
| Article | Year |
|---|---|
¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Hypoxia; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed; Triazoles | 2012 |
Automated radiosynthesis of GMP quality [18F]HX4 for PET imaging of hypoxia.
Topics: Automation; Hypoxia; Nitroimidazoles; Positron-Emission Tomography; Quality Control; Radiochemistry; Triazoles | 2015 |
Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning.
Topics: Aged; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Triazoles; Tumor Hypoxia | 2019 |